Gyre Therapeutics Inc

Small-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks

$7.30

+0.36 (+5.19%)

As of Mar 25, 2:30 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 8 89%

Hold 1 11%

Sell 0 0%

Price Target

Analyst Price Target +309.9% upside

Low Target $20.05

Average Target $29.92

High Target $33.42

Current Price $7.30

Current
$7.30

Target
$29.92

$20.05 $29.92 avg $33.42

Scenario Analysis

Bear Case

$20.05

174.7%

Low target

Base Case

$29.92

+309.9%

Avg target

Bull Case

$33.42

+357.8%

High target

Risk/Reward

2.0x

Favorable

Price in Context

52-Week High

$13.75

-46.9% from high

52-Week Low

$6.11

+19.5% from low

Target vs 52W High

$29.92

+117.6% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+24.3%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.1%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-3.7%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-89.8%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-3.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-27.6%